Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adagio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75K | Jun 22, 2022 | Direct | ||
PepGen Inc. | Director | Stock Option (Right to Buy) | 8.67K | Jun 20, 2024 | Direct | ||
Entasis Therapeutics Holdings Inc. | Director | Common Stock | 0 | $2.20 | Jul 11, 2022 | Direct | |
Entasis Therapeutics Holdings Inc. | Director | Stock Option (right to buy) | 0 | Jul 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PEPG | PepGen Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
PEPG | PepGen Inc. | Nov 10, 2023 | 1 | $0 | 4 | Nov 14, 2023 | Director |
PEPG | PepGen Inc. | Nov 10, 2023 | 0 | $0 | 3 | Nov 14, 2023 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 7, 2022 | 4 | -$109K | 4 | Jul 11, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Director |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 16, 2021 | 2 | $0 | 4 | Feb 15, 2022 | Director |